title: Reply: To PMID 23932803.
authors.forename: Min-Woong
authors.initials: MW
authors.lastname: Sohn
authors.forename: Elissa H
authors.initials: EH
authors.lastname: Oh
authors.forename: Elly
authors.initials: E
authors.lastname: Budiman-Mak
authors.forename: Todd A
authors.initials: TA
authors.lastname: Lee
authors.forename: Neil J
authors.initials: NJ
authors.lastname: Stone
authors.affiliation: Hines VA Hospital, Hines, Ill.
authors.forename: William B
authors.initials: WB
authors.lastname: Pearce
mesh_terms: D000671:Amputation, Surgical / Q000639:trends*; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D017719:Diabetic Foot / Q000188:drug therapy*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D007866:Leg / Q000601:surgery*; D008297:Male; D018570:Risk Assessment / Q000379:methods*
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors